C12N 15/8257
For the production of primary gene products
Official title: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
C12N15/8257 (For the production of primary gene products) appears on 875 US grants and 1,439 published applications in this corpus.
Search patents in C12N- Granted patents
- 875
- Published applications
- 1,439
- Assignees
- 599
- Inventors
- 2,461
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 11 | 0 |
| 1999 | 24 | 0 |
| 2000 | 23 | 0 |
| 2001 | 21 | 2 |
| 2002 | 20 | 42 |
| 2003 | 21 | 96 |
| 2004 | 20 | 74 |
| 2005 | 21 | 69 |
| 2006 | 41 | 82 |
| 2007 | 31 | 40 |
| 2008 | 35 | 65 |
| 2009 | 23 | 73 |
| 2010 | 40 | 64 |
| 2011 | 36 | 80 |
| 2012 | 37 | 75 |
| 2013 | 29 | 55 |
| 2014 | 43 | 63 |
| 2015 | 38 | 63 |
| 2016 | 35 | 62 |
| 2017 | 48 | 53 |
| 2018 | 36 | 39 |
| 2019 | 32 | 50 |
| 2020 | 29 | 41 |
| 2021 | 42 | 47 |
| 2022 | 23 | 56 |
| 2023 | 28 | 46 |
| 2024 | 25 | 45 |
| 2025 | 27 | 40 |
| 2026 | 14 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anti-viral compositions and methods of making and using6 Oct 2026US 12,753,211 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Vector for co-expressing genes of interest6 Oct 2026US 12,753,414 B2Gat Biosciences, S.L.
- Chlorella-based production of extracellular vesicle-embedded small RNAs for prophylactic or therapeutic applications22 Sep 2026US 12,742,175 B2Centre National de la Recherche Scientifique (CNRS)
- Generation of acyl amino acids28 Jul 2026US 12,692,503 B2Modular Genetics, Inc.
- Genetically engineered vegetables30 Jun 2026US 12,668,806 B2Impossible Vines Inc.
- Collagen production method8 Oct 2026US 2026/0308236 A1UniBio Corporation
- Synthesis and structure of high potency rna therapeutics10 Sep 2026US 2026/0265769 A1Arcturus Therapeutics, Inc.
- High expression of animal heme protein in plants3 Sep 2026US 2026/0258436 A1Moolec Science Limited
- Plant expressing animal milk proteins3 Sep 2026US 2026/0258437 A1Yeda Research and Development Co. Ltd.
- Methods for producing functional milk proteins in a plant cell, products and uses thereof27 Aug 2026US 2026/0250701 A1
Most cited
By later US patents
- Transgenic plants expressing assembled secretory antibodies319US 5,959,177 AThe Scripps Research Institute · 1999
- Transgenic plants expressing assembled secretory antibodies273US 6,417,429 B1The Scripps Research Institute · 2002
- Genetically engineered duckweed252US 6,040,498 ANorth Caroline State University · 2000
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Mammalian peptide expression in plant cells161US 4,956,282 ACalgene, Inc. · 1990